EMEND IV 150 MG

Pays: Israël

Langue: anglais

Source: Ministry of Health

Ingrédients actifs:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Disponible depuis:

MERCK SHARP & DOHME ISRAEL LTD

Code ATC:

A04AD12

forme pharmaceutique:

POWDER FOR SOLUTION FOR INFUSION

Mode d'administration:

I.V

Fabriqué par:

MERCK SHARP & DOHME B.V, HOLLAND

Groupe thérapeutique:

APREPITANT

indications thérapeutiques:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Date de l'autorisation:

2011-11-01